Clinical Development and Medical Affairs
Novartis leads a worldwide clinical development program.
Explore our enrolling clinical trials in the United States.
Our research strategy aims to increase collaboration across traditional scientific and organizational boundaries, and focuses on powerful new technologies that have the potential to help produce therapeutic breakthroughs.
Working closely with the care community, Novartis is currently conducting a number of clinical trials. We are committed to finding new treatment options for patients with cancer and hematologic diseases.
All compounds are either investigational or being studied for new indications. Efficacy and safety have not been established. There is no guarantee that they will become commercially available.